185 материалов по теме, собраны автоматически из проверенных источников
Hillman Cancer Center receives $5M to increase microbiome research, advance immunotherapy cancer treatment The Pitt News
Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer BioSpace
The FDA approved dostarlimab for individuals with stage II to III microsatellite instability-high/deficient mismatch repair locally advanced rectal cancer. Dostarlimab (Jemperli, GlaxoSmithKline) — a PD-1 antagonist — received accelerated approval as the first immunotherapy for this patient population. Treatment could…
Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer GSK US
Angelini Ventures and M Ventures back €120m Nouscom cancer immunotherapy round Global Venturing
Switzerland's Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials EU-Startups
Компания Neva Sgr инвестирует в Nouscom для разработки иммунотерапевтических препаратов нового поколения для лечения рака. Agenzia Nova
Nouscom concludes €120M series D to advance cancer interception immunotherapy FirstWord Pharma
ENERGIZE Trial: Can Immunotherapy Improve Perioperative Treatment in MIBC? Oncodaily
Immunotherapy-boosted chemo shows striking early results against high-risk nasopharyngeal cancer bioengineer.org
Bispecific Antibodies as a Bridge to CAR-T in DLBCL Pharmacy Practice News
MD Anderson Unveils Wave of Cancer Breakthroughs From Lung Immunotherapy to Microbiome Medicine Bioengineer.org
The Mark Foundation for Cancer Research Advances Immunotherapy for Osteosarcoma Oncodaily
Wistar Institute study identifies immunotherapy strategy for glioblastoma The Cancer Letter
CAR-T Cell Therapy Moves Beyond Cancer to Autoimmune Diseases Yale Medicine